Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neurometrix Inc (NURO) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 4,500
  • Shares Outstanding, K 5,320
  • Annual Sales, $ 7,300 K
  • Annual Income, $ -9,190 K
  • 36-Month Beta 0.19
  • Price/Sales 0.41
  • Price/Book 0.58
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -10.34
  • Most Recent Earnings N/A on N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.15 on 03/28/07
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.60 +24.00%
on 12/22/16
1.05 -29.14%
on 12/19/16
-0.28 (-27.06%)
since 12/16/16
3-Month
0.60 +24.00%
on 12/22/16
1.50 -50.40%
on 10/20/16
-0.76 (-50.40%)
since 10/18/16
52-Week
0.60 +24.00%
on 12/22/16
2.36 -68.47%
on 06/03/16
-0.88 (-54.07%)
since 01/15/16

Most Recent Stories

More News
NeuroMetrix Reports Strong Quell Demand in Q4 2016

NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO, NUROW) reported Q4 2016 demand highlights for its Quell(R) Wearable Pain Relief Technology(TM). During Q4 2016 the invoiced value of Quell...

NeuroMetrix to Present at the Digital Medicine Showcase 2017: At the Intersection of Technology and Medicine

NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Digital Medicine Showcase 2017...

CES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain

NeuroMetrix, Inc. (Nasdaq:NURO, NUROW) today announced plans to unveil important advances to its Quell(R) Wearable Pain Relief Technology(TM) at CES 2017 (CES Unveiled, Table 128 and...

NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock and Warrants

NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection...

NeuroMetrix Reports Expanded Media Coverage for Quell Wearable Pain Relief

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported increased media attention on the company's Quell(R) Wearable Pain Relief Technology(TM), including an in depth report on CBS's Innovation...

NeuroMetrix Announces That Quell Is Featured in Huffington's New Thrive Global Platform

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that its Quell(R) Wearable Pain Relief Technology(TM) is featured in the new Thrive Global commerce platform, including the online...

NeuroMetrix President and Chief Executive Officer Dr. Gozani to Speak at 2016 Connected Health Conference

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix will speak on using personal connected health for pain, addiction,...

NeuroMetrix Receives CE Mark Certification for Quell Wearable Pain Relief Device

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the CE (Conformite Europeenne) Certificate for Quell(R) has been received from TA deg V SA deg D Product Service GmbH, which is...

NeuroMetrix' Quell Device Makes Second Appearance at American Society of Regional Anesthesia's Annual Pain Medicine Meeting

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Quell(R) Wearable Pain Relief Technology(TM) will be featured for the second year in a row at the American Society for Regional...

NeuroMetrix Reports DPNCheck Introduction at the Annual Meeting of the China Diabetes Society

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today reported that DPNCheck(R), a diagnostic test for peripheral neuropathy, will be introduced at the 20th Scientific Meeting of the Chinese Diabetes...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes,...

See More

Support & Resistance

2nd Resistance Point 0.90
1st Resistance Point 0.82
Last Price 0.74
1st Support Level 0.69
2nd Support Level 0.64

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.